Bromocriptine Mesylate and Empagliflozin and Metformin Extended-Release Tablets
Determining the interaction of Bromocriptine Mesylate and Empagliflozin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and metformin, Empagliflozin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Mesylate-Empagliflozin and Metformin Tablets
- Bromocriptine Mesylate-Empliciti
- Bromocriptine Mesylate-Emsam
- Bromocriptine Mesylate-Emsam Transdermal
- Bromocriptine Mesylate-Emtricitabine
- Bromocriptine Mesylate-Emtricitabine and tenofovir
- Empagliflozin and Metformin Extended-Release Tablets-Brompheniramine
- Empagliflozin and Metformin Extended-Release Tablets-Brompheniramine and codeine
- Empagliflozin and Metformin Extended-Release Tablets-Brompheniramine and phenylephrine
- Empagliflozin and Metformin Extended-Release Tablets-Brompheniramine and Phenylephrine Chewable Tablets
- Empagliflozin and Metformin Extended-Release Tablets-Brompheniramine and Phenylephrine Liquid
- Empagliflozin and Metformin Extended-Release Tablets-Brompheniramine and Phenylephrine Suspension